Genetic Polymorphism of CYP2C9 Among Sistani Ethnic Group in Gorgan.

Cytochrome P450 2C9 (CYP2C9) is involved in metabolism of many important drugs and its genotype variations is thought to affect drug efficacy and the treatment process. The aim of this study was to assess the distribution of CYP2C9 allele and genotypic variants in Sistani ethnic group, living in Gorgan, South East of Caspian Sea and North East of Iran. This study included 140 Sistani, referred to the health center of Gorgan. CYP2C9 genotyping was carried out by polymerase chain reaction-restriction fragment length polymorphism technique. The allele frequency of CYP2C91, CYP2C92 and CYP2C93 was 76.1, 16.1 and 7.8%, respectively. The frequency of CYP2C91/1, CYP2C91/2, CYP2C91/3, CYP2C92/2, CYP2C92/3 and CYP2C93/*3 genotypes was 53.9, 22.1, 11.4, 2.9, 4.3% and nil, respectively. In this study the genotypic variations of the CYP2C9 allele among the Sistani ethnic group was investigated and great differences were observed in comparison to other populations. Our findings suggest that different genotypes of may influence the pharmacokinetics of some drugs. More studies on the pharmacokinetic effects of genotypes may help physicians choose optimal dosage of some drugs for treatment and prevention of their side effects. Since different ethnic groups from all over the world use medications, it suggests to investigate the pharmacokinetic effects of genotypes in different populations.